Potential prion risks & clearance by filtration - Strategies for process validation

被引：0
|
作者：
Aranha, H
Martin, J
机构：
[1] Pall Corp, Sci & Lab Serv Dept, Port Washington, NY USA
[2] Pall Life Sci, Biopharmaceut Grp, Port Washington, NY USA
来源：
GENETIC ENGINEERING NEWS | 2001年 / 21卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：58 / 59
页数：2
相关论文
共 50 条
  • [31] VALIDATION AND QUALITY ASSURANCE - RISK AND POTENTIAL OF PROCESS CHANGES
    WERNER, RG
    CHIMIA, 1994, 48 (10) : 460 - 464
  • [32] Process validation approach for monitoring the performance of tangential flow filtration membrane devices.
    Petrone, JT
    Erdenberger, T
    Esenther, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U208 - U208
  • [33] Respiratory tract infections during the annual Hajj: potential risks and mitigation strategies
    Al-Tawfiq, Jaffar A.
    Zumla, Alimuddin
    Memish, Ziad A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (03) : 192 - 197
  • [34] Engineered Nanomaterials and Human and Environmental Health: Research Strategies to Address Potential Risks
    Samet J.M.
    Current Environmental Health Reports, 2014, 1 (3) : 217 - 226
  • [35] Potential Risks and Mitigation Strategies Before the Conduct of a Clinical Trial: An Industry Perspective
    Bhagat, Seema
    Kapatkar, Vaibhavi K.
    Mourya, Meenakshi
    Roy, Sucheta
    Jha, Shailendra
    Reddy, Rajasekhar
    Kadhe, Ganesh
    Mane, Amey
    Sawant, Sandesh
    REVIEWS ON RECENT CLINICAL TRIALS, 2016, 11 (01) : 47 - 55
  • [36] POTENTIAL APPLICATIONS OF OPPONENT-MODEL SEARCH .2. RISKS AND STRATEGIES
    IIDA, H
    UITERWIJK, JWHM
    HERSCHBERG, IS
    VANDENHERIK, HJ
    ICCA JOURNAL, 1994, 17 (01): : 10 - 14
  • [37] Potential Risks and Mitigation Strategies During the Conduct of a Clinical Trial: An Industry Perspective
    Bhagat, Seema
    Kapatkar, Vaibhavi
    Katare, Sagar
    Mane, Ashish
    Pinto, Colette
    Pawar, Kedar
    Shah, Agam
    Barkate, Hanmant
    REVIEWS ON RECENT CLINICAL TRIALS, 2018, 13 (01) : 52 - 60
  • [38] Risk Management Strategies Mitigating Potential Severe Dermatologic Risks of Carbamazepine in Taiwan
    Huang, Yu-Wen
    Yang, Po-Wen
    Gau, Churn-Shiouh
    Tai, Hsueh-Yung
    Hsu, Chien-Wen
    Tzou, Meir-Chyun
    Lee, Hsuan-Shu
    Kang, Jaw-Jou
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S236 - S236
  • [39] Cystatin C as a Marker for Glomerular Filtration Rate in Critically Ill Neonates and Children: Validation Against Iohexol Plasma Clearance
    Smeets, Nori J. L.
    Bokenkamp, A.
    Grubb, Anders
    de Wildt, Saskia N.
    Schreuder, Michiel F.
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (08): : 1672 - 1675
  • [40] Easy to Make and to Use: The Blocking of Potential Risks in the Product Design Process
    Zong Mingming
    Xie Yong
    SELECTED PAPERS FROM IDRC ON RISK REDUCTION AND DISASTER MANAGEMENT, 2010, 1 : 167 - 173
12345